| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 10/02/2008 | WO2008119028A1 Alkenyldiarylmethanes having nitrogen-containing carboxylic acid derivatives |
| 10/02/2008 | US20080242860 Silver halide color photographic light-sensitive material and image formation method using the same, silver halide emulsion, reducing compound having group adsorptive to silver halide and method for producing the same |
| 10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
| 10/01/2008 | EP1973404A1 Malononitrile compounds |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101274916A Multifunctional bipolar carrier transmission material and application thereof |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/25/2008 | WO2008115259A2 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases |
| 09/25/2008 | US20080230747 Oxadiazole derivative and light-emitting element, light-emitting device, and electronic device in which the oxadiazole derivative is used |
| 09/24/2008 | EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/18/2008 | US20080227834 Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
| 09/12/2008 | WO2008107501A1 Composition for treating infectious diseases caused by helicobacter |
| 09/11/2008 | US20080221108 Anthranilic Acid Derivatives As Hm74A Receptor Agonists |
| 09/10/2008 | EP1966171A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof |
| 09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
| 09/04/2008 | WO2008105607A1 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists |
| 09/04/2008 | US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/03/2008 | EP1963289A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 09/03/2008 | EP1704143B1 Malononitrile compound as pesticides |
| 09/03/2008 | CN101255142A 2-substituted sulfinyl-5-(3,4,5-trialkoxy phenyl)-1,3,4-oxadiazole derivatives as well as preparation method and uses thereof |
| 09/02/2008 | US7419991 Treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders |
| 08/28/2008 | US20080207707 Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| 08/27/2008 | EP1960376A1 Oxadiazole derivatives with crth2 receptor activity |
| 08/27/2008 | EP1960351A1 Propionamide compounds as antiinflammatory agents |
| 08/27/2008 | EP1959944A1 A pharmaceutical composition comprising an amide derivative |
| 08/27/2008 | CN101253165A Di-substituted oxadiazoles as CXC-chemokine receptor ligands |
| 08/26/2008 | US7417061 Amino acid for devivering active materials; bioavailability; mixture containing oxadiazole compound |
| 08/21/2008 | US20080200445 Heterocyclic aspartyl protease inhibitors |
| 08/21/2008 | US20080199454 Caspase inhibitor prodrugs |
| 08/19/2008 | US7414142 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators |
| 08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
| 08/19/2008 | US7413536 Substrates and screening methods for transport proteins |
| 08/14/2008 | WO2008096760A1 NOVEL HEXATRIENE-β-CARBONYL COMPOUND |
| 08/13/2008 | EP1954685A2 Furoxan compounds, compositions and methods of use |
| 08/13/2008 | EP1177442B1 Determination of complex phospholipid/lipid structures using synthetic fluorescence-marked acylglycerides |
| 08/13/2008 | CN101243058A Oxadiazole derivatives as DGAT inhibitors |
| 08/13/2008 | CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410956 Caspase inhibitor prodrugs |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188453 Mapk/erk kinase inhibitors |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951653A1 Salicylic acid derivatives |
| 08/06/2008 | CN100408539C Vitamin d receptor modulators |
| 08/05/2008 | CA2279319C Benzofurazan compounds which enhance ampa receptor activity |
| 07/31/2008 | WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors |
| 07/31/2008 | WO2007124024A3 SYNTHESIS OF 5-ß-KETO-1,2,4-OXADIAZOLES AND CONVERSION OF 5-ß-KETO-1,2,4-OXADIAZOLES TO N-PYRAZOLYL AMIDOXIMES |
| 07/31/2008 | US20080182992 Mitotic Kinesin Inhibitors and Methods of Use Thereof |
| 07/31/2008 | US20080182882 E.g., N-(5-chloro-2-methylbenzyl)-N'-hydroxy-4-(hydroxymethyl)-1,2,5-oxadiazole-3-carboximidamide; inhibiting immunosuppression; treating cancer, viral infection, depression, neurodegenerative disorder, trauma, age-related cataracts, organ transplant rejection, or autoimmune disease |
| 07/30/2008 | EP1948624A2 Process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives |
| 07/29/2008 | CA2205811C Multifunctional cyanate ester and epoxy blends |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402343 Molecular chemical compounds with structures allowing electron displacement and capable of emitting photoluminescent radiation, and photoluminescence quenching device employing the same |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/17/2008 | US20080171741 e.g. 5-(4-Chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide; p38 alpha and beta kinase inhibitor; antiinflammatory agent; asthma, inflammatory bowel disease, osteoporosis, psoriasis, graft vs. host rejection, atherosclerosis, multiple myeloma, pain, myocardial ischemia |
| 07/17/2008 | US20080171377 Modulation of premature translation termination or nonsense-mediated mRNA decay |
| 07/17/2008 | US20080169448 Liquid crystalline compound, liquid crystalline composition and retardation film |
| 07/16/2008 | EP1943235A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 07/16/2008 | CN100402512C Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/10/2008 | WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/10/2008 | WO2008039431B1 Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
| 07/10/2008 | WO2008036652A3 Amidines as modulators of indoleamine 2,3-dioxygenase |
| 07/09/2008 | EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/09/2008 | EP1940811A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases |
| 07/09/2008 | CN101218214A Liquid crystal compound, liquid crystal composition, thin film, and liquid crystal display |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/03/2008 | WO2008079836A2 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/03/2008 | WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
| 07/03/2008 | CA2673598A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/02/2008 | EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
| 07/02/2008 | CN101212967A Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 07/02/2008 | CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 06/26/2008 | US20080153887 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer |
| 06/26/2008 | US20080153846 Especially 1-(5-((R)-2-Amino-1-phenylpropan-2-yl)-1,3,4-oxadiazol-2-yl)methyl)-4-butylpiperazine-2,3-dione or derivatives; amyloid precursor protein-cleaving enzyme |
| 06/26/2008 | US20080152950 Anthracene derivative and organic electroluminescent device using the same |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | CN101208082A Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/25/2008 | CN101205202A Substituted benzene urea compounds as well as preparation and uses thereof |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/24/2008 | US7390804 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/12/2008 | US20080139818 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid by reacting a cyanobenzoic acid methyl ester with hydroxylamine; acylation with a halobenzoyl chloride; condensation; and hydrolysis of the methyl ester; diseases associated with a nonsense mutation |
| 06/12/2008 | US20080139632 Such as 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-2-hydroxybenzoic acid for modulating premature translation termination or nonsense-mediated mRNA decay in cells |
| 06/12/2008 | US20080139631 3-(2-methyl-4-(trifluoromethyl)-5-cyano-indol-1-yl-methyl)-5-(3-(trifluoromethyl)phenyl)-1,2,4-oxadiazole or salt thereof; hypogonadism, sarcopenia, osteoporosis, wasting diseases, cancer cachexia, frailty, prostatic hyperplasia, prostate cancer, breast cancer; selective androgen receptor modulators |
| 06/12/2008 | US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation |
| 06/12/2008 | US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease |
| 06/12/2008 | US20080139505 Potentiators Of Glutamate Receptors |
| 06/12/2008 | US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |